Abstract:G-protein coupled receptor family C, group 5, member A, (GPRC5A) is a seven trans-membrane protein. The expression pattern of the GPRC5A gene is unique, almost exclusively in lung tissue. GPRC5A expression is frequently suppressed in human lung cancers, including lung adenocarcinoma. This suggests that inactivation of this gene may contribute to lung tumorigenesis. Indeed, we have previously found that knockout of both alleles of the mouse Gprc5a gene enhances spontaneous lung carcinogenesis. Lung epithelial cells isolated from lungs of knockout mice had a constitutively activated nuclear factor kappa B (NF-\#954;B) and tumors that developed in this model were associated with inflammatory cells. Because chronic inflammation and aberrant NF-\#954;B activation have been implicated in human lung carcinogenesis as well, in this study we explored the relationship between GPRC5A expression and NF-\#954;B activation. We found that re-expression of GPRC5A in human adenocarcinoma H1792 cells, which express low level of GPRC5A, inhibits tumor necrosis factor alpha-induced NF-\#954;B activation and suppresses the transformed phenotype (anchorage-independent growth). GPRC5A-mediated NF-\#954;B inhibition was also observed in human colon cancer cell line HCT116 and human embryonic kidney (HEK) 293 cells immortalized with sheared fragments of adenovirus (Ad)5 DNA. Inhibition of NF-\#954;B activity by GPRC5A was correlated with loss of anchorage-independent growth and increased anoikis. The mechanism of NF-\#954;B inhibition was associated with GPRC5A-mediated inhibition of I\#954;B\#945; degradation. Over-expression of GPRC5A resulted in increased formation of a complex containing \#946;-arrestin 2, I\#954;B\#945; and the NF-\#954;B subunit p65. Depletion of \#946;-arrestin 2 by siRNA restored NF-\#954;B activation in GPRC5A stable transfectants evidenced by expression of TRAF1 a downstream target of NF-\#954;B. This result suggests that increased interaction of \#946;-arrestin 2 with I\#954;B\#945;/p65 complex is involved in GPRC5A-mediated inhibition of NF-\#954;B. An analysis of 150 cases of human lung adenocarcinoma by immunohistochemical staining revealed that increased nuclear localization of NF-\#954;B indicating activation correlated with suppressed expression of GPRC5A. These results have led to the conclusion that GPRC5A functions as a physiological inhibitor of NF-\#954;B activation in lung tissue and thereby suppress carcinogenesis. Further, we propose that GPRC5A function as a tumor suppressor in human lung tissue because its deletion or repression of its expression leads to aberrant activation of NF-\#954;B pathway and tumorigenesis. Citation Information: In: Proc Am Assoc Cancer Res; 2009 Apr 18-22; Denver, CO. Philadelphia (PA): AACR; 2009. Abstract nr 5347.

Data from HP1γ Promotes Lung Adenocarcinoma by Downregulating the Transcription-Repressive Regulators NCOR2 and ZBTB7A

Histone Demethylase RBP2 Promotes Lung Tumorigenesis and Cancer Metastasis.

Inhibition of HIST1H2AB Suppresses the Proliferation of Lung Adenocarcinoma

Epigenetic Modifications Promote the Expression of the Orphan Nuclear Receptor NR0B1 in Human Lung Adenocarcinoma Cells

Long non‐coding RNA H19 is responsible for the progression of lung adenocarcinoma by mediating methylation‐dependent repression of CDH1 promoter

HOXD1 inhibits lung adenocarcinoma progression and is regulated by DNA methylation

YAP Mediates the Positive Regulation of Hnrnpk on the Lung Adenocarcinoma H1299 Cell Growth.

Loss of Hypermethylated in Cancer 1 (HIC1) Promotes Lung Cancer Progression.

Suppression of Lung Adenocarcinoma Through Menin and Polycomb Gene-Mediated Repression of Growth Factor Pleiotrophin

H3K9 methyltransferases and demethylases control lung tumor-propagating cells and lung cancer progression

COPB2 Promotes Cell Proliferation and Tumorigenesis Through Up-Regulating YAP1 Expression in Lung Adenocarcinoma Cells.

NcRNA-Mediated High Expression of HMMR as a Prognostic Biomarker Correlated With Cell Proliferation and Cell Migration in Lung Adenocarcinoma

HMGN1 loss sensitizes lung cancer cells to chemotherapy

Downregulation of m6A Reader YTHDC2 Promotes the Proliferation and Migration of Malignant Lung Cells via CYLD/NF-κB Pathway.

Abstract 1019: Hnrnpa2/b1 Upregulates COX-2 Expression and Tumor Growth and Predicts Poor Prognosis in Human Lung Cancers

The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma.

CBX2 and EZH2 Cooperatively Promote the Growth and Metastasis of Lung Adenocarcinoma

Novel role of CAP1 in regulation RNA polymerase II-mediated transcription elongation depends on its actin-depolymerization activity in nucleoplasm

BDH1‐mediated LRRC31 Regulation Dependent on Histone Lysine Β‐hydroxybutyrylation to Promote Lung Adenocarcinoma Progression

Methyl-CpG Binding Domain Protein 2 Inhibits the Malignant Characteristic of Lung Adenocarcinoma Through the Epigenetic Modulation of 10 to 11 Translocation 1 and Mir-200S.

Abstract #5347: the Lung Tumor Suppressor GPRC5A Inhibits Activation of NF-\#954;B in Human Non-Small Cell Lung Adenocarcinoma Cells